These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2924878

  • 1. Leishmania major: histopathological responses before and after topical treatment in experimental animals.
    El-On J, Lang E, Kuperman O, Avinoach I.
    Exp Parasitol; 1989 Feb; 68(2):144-54. PubMed ID: 2924878
    [Abstract] [Full Text] [Related]

  • 2. Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.
    el-On J, Weinrauch L, Livshin R, Even-Paz Z, Jacobs GP.
    Br Med J (Clin Res Ed); 1985 Sep 14; 291(6497):704-5. PubMed ID: 3929905
    [No Abstract] [Full Text] [Related]

  • 3. Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycin.
    Carter KC, Alexander J, Baillie AJ.
    Ann Trop Med Parasitol; 1989 Jun 14; 83(3):233-9. PubMed ID: 2604461
    [Abstract] [Full Text] [Related]

  • 4. Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals.
    el-On J, Hamburger AD.
    Trans R Soc Trop Med Hyg; 1987 Jun 14; 81(5):734-7. PubMed ID: 3449988
    [Abstract] [Full Text] [Related]

  • 5. Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.
    el-On J, Sneier R, Elias E.
    Isr J Med Sci; 1992 Dec 14; 28(12):847-51. PubMed ID: 1286954
    [Abstract] [Full Text] [Related]

  • 6. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
    el-On J, Sulitzeanu A, Schnur LF.
    Ann Trop Med Parasitol; 1991 Jun 14; 85(3):323-8. PubMed ID: 1746981
    [Abstract] [Full Text] [Related]

  • 7. Leishmania aethiopica: topical treatment with paromomycin and methylbenzethonium chloride ointment.
    Weinrauch L, Katz M, el-On J.
    J Am Acad Dermatol; 1987 Jun 14; 16(6):1268-70. PubMed ID: 3597872
    [No Abstract] [Full Text] [Related]

  • 8. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
    el-On J, Halevy S, Grunwald MH, Weinrauch L.
    J Am Acad Dermatol; 1992 Aug 14; 27(2 Pt 1):227-31. PubMed ID: 1430361
    [Abstract] [Full Text] [Related]

  • 9. Topical treatment of cutaneous leishmaniasis.
    El-On J, Livshin R, Even-Paz Z, Hamburger D, Weinrauch L.
    J Invest Dermatol; 1986 Aug 14; 87(2):284-8. PubMed ID: 3734476
    [Abstract] [Full Text] [Related]

  • 10. Protection of guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy.
    El-On J, Witztum A, Schnur LF.
    Infect Immun; 1986 Feb 14; 51(2):704-6. PubMed ID: 3943909
    [Abstract] [Full Text] [Related]

  • 11. Topical treatment of cutaneous leishmaniasis.
    el-On J, Livshin R, Paz ZE, Weinrauch L.
    Br Med J (Clin Res Ed); 1985 Nov 02; 291(6504):1280-1. PubMed ID: 3933633
    [No Abstract] [Full Text] [Related]

  • 12. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M, Schuster BG, Ellis WY, Berman JD.
    J Parasitol; 1999 Apr 02; 85(2):354-9. PubMed ID: 10219319
    [Abstract] [Full Text] [Related]

  • 13. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
    Krause G, Kroeger A.
    Clin Infect Dis; 1999 Aug 02; 29(2):466-7. PubMed ID: 10476776
    [No Abstract] [Full Text] [Related]

  • 14. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
    El-On J, Bazarsky E, Sneir R.
    Exp Parasitol; 2007 Jun 02; 116(2):156-62. PubMed ID: 17306255
    [Abstract] [Full Text] [Related]

  • 15. Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals.
    El-On J, Jacobs GP, Witztum E, Greenblatt CL.
    Antimicrob Agents Chemother; 1984 Nov 02; 26(5):745-51. PubMed ID: 6517557
    [Abstract] [Full Text] [Related]

  • 16. Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.
    Krause G, Kroeger A.
    Trans R Soc Trop Med Hyg; 1994 Nov 02; 88(1):92-4. PubMed ID: 8154018
    [Abstract] [Full Text] [Related]

  • 17. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LA.
    J Antimicrob Chemother; 2009 Dec 02; 64(6):1234-40. PubMed ID: 19825819
    [Abstract] [Full Text] [Related]

  • 18. [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
    Schallreuter KU, Lemke KR.
    Hautarzt; 1994 Nov 02; 45(11):783-6. PubMed ID: 7822205
    [Abstract] [Full Text] [Related]

  • 19. Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.
    Aguiar MG, Pereira AM, Fernandes AP, Ferreira LA.
    Antimicrob Agents Chemother; 2010 Nov 02; 54(11):4699-704. PubMed ID: 20713665
    [Abstract] [Full Text] [Related]

  • 20. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.
    Neal RA, Murphy AG, Olliaro P, Croft SL.
    Trans R Soc Trop Med Hyg; 1994 Nov 02; 88(2):223-5. PubMed ID: 8036682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.